The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis - Narita, Takuma; Koie, Takuya; Ookubo, Teppei; Mitsuzuka, Koji; Narita, Shintaro; Yamamoto, Hayato; Inoue, Takamitsu; Hatakeyama, Shingo; Kawamura, Sadafumi; Tochigi, Tatsuo; Habuchi, Tomonori; Arai, Yoichi; et al. (Medical oncology (Northwood, London, England), 2017)
Keywords: Aged; Antibiotics, Antineoplastic - therapeutic use; Chemotherapy, Adjuvant; Estramustine - administration & dosage; Gonadotropin-Releasing Hormone - administration & dosage; Hematology; Humans; Internal Medicine; Lymph Node Excision; Lymph Nodes - pathology; Lymph Nodes - surgery; Male; Medicine; Medicine & Public Health; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - prevention & control; Oncology; Original Paper; Pathology; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - pathology; Prostatic Neoplasms - surgery; Retrospective Studies; Risk Factors; Neoadjuvant therapy; Prostatectomy; Extended lymph node dissection; High-risk prostate cancer